表紙
市場調查報告書

全球電穿孔設備市場:2020年∼2024年的預測

Global Electroporation Instruments Market 2020-2024

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 711729
出版日期 內容資訊 英文 120 Pages
訂單完成後即時交付
價格
全球電穿孔設備市場:2020年∼2024年的預測 Global Electroporation Instruments Market 2020-2024
出版日期: 2019年12月27日內容資訊: 英文 120 Pages
簡介

全球電穿孔設備市場在預測期間內預計將以7%的年複合成長率成長,2024年達到7,267萬美元的規模。該市場的成長,由單株抗體的需求高漲所帶動。再加上生物醫藥品的高需求預期推動該市場的成長。

本報告提供全球電穿孔設備市場的相關調查,各終端用戶、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

摘要整理

  • 市場概況

市場情況

  • 市場生態系統
  • 價值鏈分析

市場規模

  • 市場定義
  • 市場區隔分析
  • 市場規模
  • 市場預測:2019-2024年的預測

波特的五力分析

  • 五力摘要
  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 對手的威脅
  • 市場情況

市場分析:各終端用戶

  • 市場區隔
  • 比較
  • 製藥及生物科技企業
  • 學術研究機關
  • CRO
  • 市場機會

客戶的風景

  • 概要

市場分析:各地區

  • 市場區隔
  • 比較
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲
  • 主要國家
  • 市場機會

成長要素,課題,及趨勢

  • 市場成長要素
  • 交易量成長要素-需求主導的成長
  • 交易量成長要素-供給主導的成長
  • 交易量成長要素-外部要素
  • 交易量成長要素-相關市場上的需求轉移
  • 價格成長要素-通貨膨脹
  • 價格成長要素-從低價格轉移到高價格
  • 市場課題
  • 市場趨勢

業者情勢

  • 概要
  • 業者情勢
  • 形勢的創新

供應商分析

  • 交易廠商
  • 供應商的市場定位
  • BEX Co. Ltd.
  • Bio-Rad Laboratories Inc.
  • Celetrix LLC
  • Cellectricon AB
  • Eppendorf AG
  • Harvard Bioscience Inc.
  • Lonza Group Ltd.
  • MaxCyte Inc.
  • Merck KGaA
  • Thermo Fisher Scientific Inc.

附錄

  • 報告的範圍
  • 美金的匯率
  • 調查方法
  • 簡稱的清單
目錄
Product Code: IRTNTR40621

Technavio has been monitoring the global electroporation instruments market and it is poised to grow by USD 72.67 mn during 2020-2024, progressing at a CAGR of 7% during the forecast period. Our reports on electroporation instruments market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by rising demand for monoclonal antibodies. In addition, high demand for biopharmaceuticals is anticipated to boost the growth of the electroporation instruments market as well.

Market Segmentation

Technavio's global electroporation instruments market is segmented as below:

End-user

  • Pharma and biotech companies
  • Academic and research institutes
  • CROs

Geographic segmentation

  • North America
  • APAC
  • Europe
  • South America
  • MEA

Key Trends for electroporation instruments market growth

This study identifies high demand for biopharmaceuticals as the prime reasons driving the electroporation instruments market growth during the next few years.

Prominent vendors in electroporation instruments market

We provide a detailed analysis of around 25 vendors operating in the electroporation instruments market, including some of the vendors such as BEX Co. Ltd., Bio-Rad Laboratories Inc., Celetrix LLC, Cellectricon AB, Eppendorf AG, Harvard Bioscience Inc., Lonza Group Ltd., MaxCyte Inc., Merck KGaA and Thermo Fisher Scientific Inc.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five Forces Summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by End-user

  • Market segments
  • Comparison by End user placement
  • Pharma and biotech companies - Market size and forecast 2019-2024
  • Academic and research institutes - Market size and forecast 2019-2024
  • CROs - Market size and forecast 2019-2024
  • Market opportunity by End user

Customer landscape

  • Overview

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • APAC - Market size and forecast 2019-2024
  • South America - Market size and forecast 2019-2024
  • MEA - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography

Drivers, Challenges, and Trends

  • Market drivers
  • Volume driver - Demand led growth
  • Volume driver - Supply led growth
  • Volume driver - External factors
  • Volume driver - Demand shift in adjacent markets
  • Price driver - Inflation
  • Price driver - Shift from lower to higher-priced units
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Vendor landscape
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • BEX Co. Ltd.
  • Bio-Rad Laboratories Inc.
  • Celetrix LLC
  • Cellectricon AB
  • Eppendorf AG
  • Harvard Bioscience Inc.
  • Lonza Group Ltd.
  • MaxCyte Inc.
  • Merck KGaA
  • Thermo Fisher Scientific Inc.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations